C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/395 (2006.01) A61K 31/695 (2006.01) C07D 519/00 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2180253
The present invention relates to a novel pyrazolopyridine compound of formula (I) wherein R1 is aryl, and R2 is cyclo(lower)alkyl which may have one or more suitable substitutent(s), etc; and a pharmaceutically acceptable salt thereof, which is useful as a medicament. The pyrazolopyridine compound or a pharmaceutically acceptable salt thereof is an adenosine antagonist (especially, A1 receptor antagonist) and possesses various pharmacological actions.
L'invention concerne un nouveau composé pyrazolopyridine de formule (I), dans laquelle R?1¿ désigne aryle, et R?2¿ désigne cycloalkyle (inférieur) qui peut avoir un ou plusieurs substituants appropriés, etc.; et un de ses sels acceptable sur le plan pharmaceutique, qui s'utilise comme médicament. Un tel composé pyrazolopyridine ou son sel acceptable sur le plan pharmaceutique est un antagoniste de l'adénosine (notamment un antagoniste du récepteur A¿1?) et présente différents effets pharmacologiques.
Akahane Atsushi
Durkin Kieran P. M.
Itani Hiromichi
Nishimura Shintaro
Fujisawa Pharmaceutical Co. Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Pyrazolopyridine adenosine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyridine adenosine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyridine adenosine antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1449502